Strain identification of commercial influenza vaccines by mass spectrometry
Authors:
- Marybeth C. CreskeyMCMarybeth C. Creskey
- Daryl G.S. SmithDSDaryl G.S. Smith
- Terry D. CyrTCTerry D. Cyr
- 1 November 2010
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 406 (2) , 193-203
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline
This publication has 26 references indexed in Scilit:
- Typing of human and animal strains of influenza virus with conserved signature peptides of matrix M1 protein by high resolution mass spectrometryJournal of Virological Methods, 2010
- Quantitative analysis of cellular proteome alterations in human influenza A virus‐infected mammalian cell linesProteomics, 2009
- Subtyping of the Influenza Virus by High Resolution Mass SpectrometryAnalytical Chemistry, 2009
- Selective and Quantitative Detection of Influenza Virus Proteins in Commercial Vaccines Using Two-Dimensional High-Performance Liquid Chromatography and Fluorescence DetectionAnalytical Chemistry, 2007
- Rapid and selective characterization of influenza virus constituents in monovalent and multivalent preparations using non-porous reversed-phase high performance liquid chromatography columnsJournal of Chromatography A, 2006
- Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6® cells: A novel RP-HPLC methodVaccine, 2006
- Realities and enigmas of human viral influenza: pathogenesis, epidemiology and controlVaccine, 2002
- Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccinesVeterinary Microbiology, 1993
- Rates of spontaneous mutation among RNA viruses.Proceedings of the National Academy of Sciences, 1993
- An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccinesJournal of Biological Standardization, 1977